Cannon NA - Search Results

1

Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.

Cannon NA, Iyengar P, Choy H, Timmerman R, Meyer J. Cannon NA, et al. BMC Cancer. 2014 Dec 17;14:971. doi: 10.1186/1471-2407-14-971. BMC Cancer. 2014. PMID: 25518879 Free PMC article.

2

Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus.

Hannan R, Margulis V, Chun SG, Cannon N, Kim DW, Abdulrahman RE, Sagalowsky A, Pedrosa I, Choy H, Brugarolas J, Timmerman RD. Hannan R, et al. Cancer Biol Ther. 2015;16(5):657-61. doi: 10.1080/15384047.2015.1026506. Cancer Biol Ther. 2015. PMID: 25800036 Free PMC article.

3

Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.

Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, Timmerman R. Cannon NA, et al. J Thorac Oncol. 2015 Feb;10(2):280-5. doi: 10.1097/JTO.0000000000000399. J Thorac Oncol. 2015. PMID: 25299234 Free article.

4

Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters.

Zhou Z, Folkert M, Cannon N, Iyengar P, Westover K, Zhang Y, Choy H, Timmerman R, Yan J, Xie XJ, Jiang S, Wang J. Zhou Z, et al. Radiother Oncol. 2016 Jun;119(3):501-4. doi: 10.1016/j.radonc.2016.04.029. Epub 2016 May 5. Radiother Oncol. 2016. PMID: 27156652 Free PMC article.

5

Prevalence and Survival Impact of Pretreatment Cancer-Associated Weight Loss: A Tool for Guiding Early Palliative Care.

Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P. Gannavarapu BS, et al. Among authors: cannon na. J Oncol Pract. 2018 Apr;14(4):e238-e250. doi: 10.1200/JOP.2017.025221. Epub 2018 Feb 21. J Oncol Pract. 2018. PMID: 29466074 Free PMC article.

6

Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy.

Cannon NA, Donlin MJ, Fan X, Aurora R, Tavis JE; Virahep-C Study Group. Cannon NA, et al. PLoS One. 2008 May 7;3(5):e2123. doi: 10.1371/journal.pone.0002123. PLoS One. 2008. PMID: 18463735 Free PMC article.

7

Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.

Cannon NA, Donlin MJ, Mayes LM, Lyra AC, Di Bisceglie AM, Tavis JE. Cannon NA, et al. J Viral Hepat. 2009 Aug;16(8):595-604. doi: 10.1111/j.1365-2893.2009.01109.x. Epub 2009 Feb 23. J Viral Hepat. 2009. PMID: 19243495 Free PMC article.

8

Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy.

Donlin MJ, Cannon NA, Yao E, Li J, Wahed A, Taylor MW, Belle SH, Di Bisceglie AM, Aurora R, Tavis JE; Virahep-C Study Group. Donlin MJ, et al. Among authors: cannon na. J Virol. 2007 Aug;81(15):8211-24. doi: 10.1128/JVI.00487-07. Epub 2007 May 23. J Virol. 2007. PMID: 17522222 Free PMC article. Clinical Trial.

9

Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans.

Aurora R, Donlin MJ, Cannon NA, Tavis JE. Aurora R, et al. Among authors: cannon na. J Clin Invest. 2009 Jan;119(1):225-36. doi: 10.1172/JCI37085. Epub 2008 Dec 22. J Clin Invest. 2009. PMID: 19104147 Free PMC article.

10

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

Donlin MJ, Cannon NA, Aurora R, Li J, Wahed AS, Di Bisceglie AM, Tavis JE; Virahep-C Study Group. Donlin MJ, et al. Among authors: cannon na. PLoS One. 2010 Feb 3;5(2):e9032. doi: 10.1371/journal.pone.0009032. PLoS One. 2010. PMID: 20140258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters